Treatment for Brachioradial Pruritus
For brachioradial pruritus, a multimodal approach is recommended with gabapentin, pregabalin, or capsaicin cream as first-line treatments based on their effectiveness in reducing neuropathic itch and improving quality of life.
Understanding Brachioradial Pruritus
Brachioradial pruritus (BRP) is a specific type of neuropathic pruritus that primarily affects the dorsolateral aspects of the forearms, particularly over the brachioradialis muscle. It presents with:
- Intense itching, burning, or pain in the affected areas
- Typically bilateral involvement (72% of cases)
- More common in fair-skinned individuals
- Often exacerbated by sun exposure
- Frequently associated with cervical spine pathology
Treatment Algorithm
First-line Treatments:
Topical Therapies:
Systemic Medications:
Second-line Treatments:
Combination therapy:
- H1 and H2 antagonists together (e.g., fexofenadine and cimetidine) 2
Other medications to consider:
Phototherapy:
- NB-UVB or BB-UVB may provide temporary relief 2
Treatment Considerations
Addressing Underlying Causes:
- Cervical spine evaluation: Since BRP is often associated with cervical radiculopathy (57% of patients in one study showed abnormal F responses diagnostic for cervical radiculopathy) 5
- Sun protection: As UV exposure can trigger or worsen symptoms 1, 4
Important Caveats:
When using capsaicin cream:
When using topical doxepin:
- Limit treatment to 8 days
- Apply to no more than 10% of body surface area (maximum 12g daily)
- Risk of allergic contact dermatitis 2
Avoid ineffective treatments:
Monitoring and Follow-up
- Reassess after 2 weeks of treatment
- If symptoms worsen or do not improve, escalate to the next treatment option
- For grade 3 (intense, widespread, constant, limiting self-care) or intolerable grade 2 pruritus, consider combination therapy 2
BRP can be challenging to diagnose and treat, with diagnosis often delayed by 2-3 years 4. Early recognition and appropriate treatment can significantly improve quality of life for affected patients.